NYSE - Delayed Quote USD

Kenvue Inc. (KVUE)

Compare
23.19 -0.20 (-0.86%)
At close: September 18 at 4:00 PM EDT
23.17 -0.02 (-0.09%)
After hours: September 18 at 7:43 PM EDT
Loading Chart for KVUE
DELL
  • Previous Close 23.39
  • Open 23.44
  • Bid 23.20 x 1200
  • Ask 23.21 x 1100
  • Day's Range 23.08 - 23.52
  • 52 Week Range 17.67 - 23.55
  • Volume 15,225,491
  • Avg. Volume 17,371,003
  • Market Cap (intraday) 44.413B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 40.68
  • EPS (TTM) 0.57
  • Earnings Date Oct 24, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 0.82 (3.51%)
  • Ex-Dividend Date Aug 14, 2024
  • 1y Target Est 22.15

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

www.kenvue.com

22,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KVUE

View More

Performance Overview: KVUE

Trailing total returns as of 9/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

KVUE
11.04%
S&P 500
17.79%

1-Year Return

KVUE
13.84%
S&P 500
26.24%

3-Year Return

KVUE
9.17%
S&P 500
38.34%

5-Year Return

KVUE
9.17%
S&P 500
38.34%

Compare To: KVUE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KVUE

View More

Valuation Measures

Annual
As of 9/17/2024
  • Market Cap

    44.80B

  • Enterprise Value

    52.39B

  • Trailing P/E

    41.04

  • Forward P/E

    18.94

  • PEG Ratio (5yr expected)

    6.44

  • Price/Sales (ttm)

    2.90

  • Price/Book (mrq)

    4.40

  • Enterprise Value/Revenue

    3.39

  • Enterprise Value/EBITDA

    20.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.23%

  • Return on Assets (ttm)

    6.97%

  • Return on Equity (ttm)

    10.55%

  • Revenue (ttm)

    15.48B

  • Net Income Avi to Common (ttm)

    1.12B

  • Diluted EPS (ttm)

    0.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.01B

  • Total Debt/Equity (mrq)

    84.56%

  • Levered Free Cash Flow (ttm)

    1.99B

Research Analysis: KVUE

View More

Company Insights: KVUE

Research Reports: KVUE

View More

People Also Watch